| dc.description.abstract | The use of Positron Emission Tomography/Computed Tomography (PET/CT) imaging has
become more popular in oncology. A concern with PET/CT is the combined radiation
doses from both CT and radiopharmaceuticals. A Diagnostic Reference Level (DRL) is
an e ective tool for optimizing patient and sta radiation exposure while maintaining
adequate diagnostic image quality. The aim of this study is to optimize the patient radiation
dose by establishing institutional DRLs for whole-body PET/CT imaging procedures
performed at Apeksha hospital in Maharagama, Colombo, Sri Lanka. A total of 86
imaging procedures was selected for this study. All data were collected from September
2022 to November 2022. The median (50th percentile) of the administered activity,
Dose Length Product (DLP) and CTDIvol values were considered as the DRL values as
recommended by the International Commission of Radiological Protection (ICRP). The
median values of the administered activity, e ective dose, total DLP and CTDIvol were
reported as 184.26 MBq, 3.50 mSv, 1407.5 mGy.cm and 7.51 mGy respectively. According
to the ICRP recommendation, the established DRL values for administered activity, total
DLP and CTDIvol for PET/CT whole-body scan procedures performed in the PET/CT
Unit of Apeksha Hospital are 184.26 MBq, 1407.5 mGy.cm and 7.51 mGy respectively. This
study is an initiative process of developing national DRLs for PET/CT imaging procedures
in Sri Lanka. Furthermore, a signi cant statistical correlation was found in between the
e ective dose and patients’ body mass index. In addition, a signi cant relationship was
found in between e ective dose and patients’ clinical indication. | en_US |
